ICON Public (NASDAQ:ICLR) Updates FY 2024 Earnings Guidance

ICON Public (NASDAQ:ICLR) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share guidance of 13.900-14.100 for the period, compared to the consensus earnings per share estimate of 13.970. The company issued revenue guidance of $8.3 billion-$8.3 billion, compared to the consensus revenue estimate of $8.3 billion. ICON Public also updated its FY 2025 guidance to 13.000-15.000 EPS.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on ICLR shares. Citigroup lowered their target price on shares of ICON Public from $300.00 to $290.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Robert W. Baird lowered their price objective on ICON Public from $249.00 to $225.00 and set a “neutral” rating for the company in a research report on Wednesday, November 20th. StockNews.com lowered ICON Public from a “buy” rating to a “hold” rating in a research report on Thursday, September 19th. Leerink Partners restated an “outperform” rating and set a $255.00 target price (down previously from $270.00) on shares of ICON Public in a research note on Tuesday, November 19th. Finally, Leerink Partnrs upgraded shares of ICON Public to a “strong-buy” rating in a research note on Wednesday, September 18th. Four investment analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $287.00.

ICON Public Stock Down 8.1 %

Shares of NASDAQ:ICLR opened at $200.24 on Wednesday. ICON Public has a 1-year low of $183.38 and a 1-year high of $347.72. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.34 and a quick ratio of 1.34. The stock has a market cap of $16.52 billion, a P/E ratio of 22.32, a P/E/G ratio of 1.54 and a beta of 1.20. The firm has a fifty day moving average price of $211.31 and a 200 day moving average price of $270.81.

ICON Public (NASDAQ:ICLR) last announced its earnings results on Wednesday, October 23rd. The medical research company reported $3.35 earnings per share for the quarter, missing the consensus estimate of $3.72 by ($0.37). The business had revenue of $2.03 billion for the quarter, compared to analyst estimates of $2.13 billion. ICON Public had a return on equity of 11.91% and a net margin of 9.00%. ICON Public’s quarterly revenue was down 1.2% on a year-over-year basis. During the same quarter last year, the company posted $3.10 EPS. Sell-side analysts predict that ICON Public will post 13.42 EPS for the current year.

ICON Public Company Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.